Contact Us
Subscribe
E-Edition

39°

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
Sports
Obits
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Subscribe
Archives
Best of 2025
Pet Contest

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Articles published by Enveric Biosciences

< Previous 1 2 3 Next >

Enveric Biosciences Announces Manuscript Describing the Development of Lead Product Candidate, EB-373, to be Featured on the Cover of the Journal of Medicinal Chemistry

November 27, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Announces Presentation of Two Posters at Canadian Chemical Engineering Conference (CSChE 2023)

November 24, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences to Present at the Centurion One 5th Global Summit

October 20, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Initiates GLP Toxicology & Safety Pharmacology Studies for Lead Candidate EB-373, a Next Generation Psilocin Prodrug Targeting Psychiatric Disorders

October 18, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Announces Two Poster Presentations at the 6th Neuropsychiatric Drug Development Summit

October 11, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Announces its Psybrary™ Portfolio Now Totals Over 1000 Psychedelic-Inspired Therapeutic Candidates

October 03, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Announces Publication of a Paper Describing a Novel Bioproduction Platform for Psychedelic-Inspired Drug Discovery in the Journal of Biological Chemistry

September 27, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Expands IP Portfolio with New U.S. Patent for Novel Carboxylated Psilocybin Derivatives Supporting its EVM301 Series of Drug Candidates

September 20, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences to Present Poster Highlighting EVM301 Series at the International Conference on Molecular Biology and Biochemistry 2023

September 18, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Files Provisional Patent Application for AI-based Computational Methods for Identifying and Optimizing Novel Tryptamine Derivatives

September 11, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Announces New U.S. Patent for C4-Carboxylic Acid-Substituted Tryptamine Derivatives

September 05, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences to Present at H.C. Wainwright 25th Annual Global Conference

August 30, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Strengthens Intellectual Property Portfolio with New U.S. Patent for Tryptamine-derived Prodrugs

August 28, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Completes Manufacturing of EB-373 to Supply Drug Material for Completion of Preclinical Program

August 21, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Reports Positive Results from Preclinical Studies Supporting Metabolic Profile of Lead Candidate EB-373

July 24, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Reports Positive Results from Animal Studies Demonstrating Oral Bioavailability and Well Tolerated Side Effect Profile for EB-373

July 17, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Announces Development of Phase 1-Ready Formulation for EB-373 and Initiation of Scaled Up Manufacturing

June 26, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences to Present at H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference

June 12, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences to Participate in Benzinga Psychedelics Capital Conference

April 10, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373

March 23, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Establishes Australia-based Subsidiary to Accelerate its Lead Psilocin Prodrug Program Targeting Mental Health Indications

March 21, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Announces Bioproduction Platform Using Novel Cane Toad Enzyme for Psychedelic-Inspired Drug Discovery

March 14, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Appoints Kevin Coveney as Chief Financial Officer, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

February 28, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Names Lynn Gallant Vice President, Clinical Operations, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

February 23, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences to Present at the Gravitas Securities Inc. 6th Annual Growth Conference

February 22, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences to Present at the BIO CEO & Investor Conference

February 01, 2023

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences to Present at the 6th Annual Neuroscience Innovation Forum and Biotech Showcase during "J.P. Morgan Health Care Week 2023"

December 21, 2022

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences Announces Confidential Submission of Registration Statement for the Spin-off of its Cannabinoid Business to Shareholders

November 28, 2022

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences to Participate in A.G.P.’s Virtual Biotech Conference

November 16, 2022

From Enveric Biosciences

Via Business Wire

Tickers ENVB

Enveric Biosciences to Participate in Wonderland: Miami on November 3-5, 2022

November 01, 2022

From Enveric Biosciences

Via Business Wire

Tickers ENVB

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

starkvilledailynews.com
304 E. Lampkin Street,
Starkville, MS 39759
Phone: 662-323-1642
Email: editor@starkvilledailynews.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Articles published by Enveric Biosciences

Sections

Services

Follow Us